New Rule: Real-Time Drug Prices and Electronic Prior Authorizations

A regulatory change finalized by the US Department of Health and Human Services (HHS) will allow clinicians to submit prior authorizations electronically and compare prescription drug prices to find lower-cost alternatives for their patients.

Authors

Publication Details

Journal
JAMA
Published
2025-09-19
DOI
https://doi.org/10.1001/jama.2025.13879
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New Rule: Real-Time Drug Prices and Electronic Prior Authorizations

Samantha Anderer
JAMA
Pharmaceutical Economics and Policy
article

New Rule: Real-Time Drug Prices and Electronic Prior Authorizations

Samantha Anderer
article en

Abstract

A regulatory change finalized by the US Department of Health and Human Services (HHS) will allow clinicians to submit prior authorizations electronically and compare prescription drug prices to find lower-cost alternatives for their patients.

JAMAVol. 334(15)
Openalex Percentile: Top 66%
Pharmaceutical Economics and Policy
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

New Rule: Real-Time Drug Prices and Electronic Prior Authorizations — Samantha Anderer · JAMA (2025) | TGRS Research Map | TGRS